Researchers have developed an infrared-based sensor that detects misfolded alpha-synuclein protein in spinal fluid with ...

This milestone launches dapansutrile into Phase 2 clinical development for neurological conditions, expanding upon ongoing trials with dapansutrile in rheumatologic diseases (Phas ...

Renowned neuroscience leader to help evaluate and guide Parkinson's research fundingNEW YORK, March 25, 2026 /PRNewswire/ -- ...

Doctors often struggle to distinguish early dementia with Lewy bodies from early Parkinson's disease. The two neurological ...

Learn expert tips on preparing for the conversation, explaining disease progression, and discussing legal and financial plans to ensure that your wishes are met.

Progressive supranuclear palsy, or PSP, is a rare brain disease that causes problems with balance, eye movements and thinking ...

At AD/PD 2026, Roche announced that patients treated with prasinezumab for five years demonstrated a sustained slowing of ...

Drawing from UK Biobank data, Mass General Brigham researchers have uncovered specific health factors linked to higher or lower risk of developing progressive supranuclear palsy (PSP), a rare but ...

Cohen says he looked at around two dozen companies since Acorda wound down. Oryon Cell Therapies, with its funding, data and ...

Now, researchers have developed an online decision-making tool to help patients understand the implants and boost their ...

A pesticide commonly used in America’s food supply has been linked to Parkinson’s disease, new research suggests.

At AD/PD 2026, one message stood out: when researchers share ideas across Alzheimer’s and Parkinson’s, it could help speed up ...